PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 158 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $9,611,000 | -48.4% | 209,624 | -33.5% | 0.32% | -51.9% |
| Q2 2018 | $18,634,000 | -13.1% | 315,024 | -0.0% | 0.68% | -19.7% |
| Q1 2018 | $21,445,000 | -32.3% | 315,135 | -1.6% | 0.84% | -33.2% |
| Q4 2017 | $31,666,000 | -9.2% | 320,343 | +10.0% | 1.26% | -13.4% |
| Q3 2017 | $34,865,000 | +60.8% | 291,146 | +17.4% | 1.45% | +53.8% |
| Q2 2017 | $21,679,000 | +123.4% | 248,038 | -4.9% | 0.94% | +112.8% |
| Q1 2017 | $9,702,000 | +84.7% | 260,817 | +890.9% | 0.44% | +3.3% |
| Q1 2015 | $5,253,000 | -36.2% | 26,322 | -39.5% | 0.43% | -39.9% |
| Q4 2014 | $8,239,000 | +43.9% | 43,533 | +81.4% | 0.72% | +30.2% |
| Q3 2014 | $5,726,000 | – | 24,000 | – | 0.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |